Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2025-12-25 @ 2:32 AM
NCT ID:
NCT02268734
Eligibility Criteria:
Inclusion Criteria:
* diagnosis of sMTC surgically treated (total thyroidectomy)
* locally relapsed and or metastatic sMTC
* metastatic MTC never treated with TKI before (valid for subjects treated with vandetanib only, in whom we will investigate the variation of circulating miRNA profile before and after vandetanib administration).
Exclusion Criteria:
* Patients with severe infection, active clinical co-morbidities, or a history of any other malignancy have been excluded.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02268734
Study Brief:
Protocol Section:
NCT02268734